Skip to main content

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Cancer Imaging operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

All manuscripts are assessed and handled by the appropriate Section Editor. After an initial screening for general suitability, submissions are sent to at least two experts in the field who are asked to evaluate whether the manuscript is scientifically sound and coherent and whether the manuscript should be accepted, rejected or revised. Final decisions are made by the Editors-in-Chief based on the recommendations of Section Editors and reviewer reports.

The journal aims to provide authors with a first decision (accepted/rejected/revisions needed) within six weeks.

Official journal of

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.5
    5-year Journal Impact Factor: 4.3
    Source Normalized Impact per Paper (SNIP): 1.416
    SCImago Journal Rank (SJR): 1.227

    Speed 2023
    Submission to first editorial decision (median days): 13
    Submission to acceptance (median days): 123

    Usage 2023
    Downloads: 1,045,188
    Altmetric mentions: 349

Download journal leaflet